110
Views
30
CrossRef citations to date
0
Altmetric
Case Report

Refractory Hypoglycemia from Ciprofloxacin and Glyburide Interaction

, M.D., , Pharm.D. & , M.D.
Pages 295-297 | Received 24 Jul 2003, Accepted 28 Jan 2004, Published online: 16 Aug 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jeffrey S Freeman & Benjamin Gross. (2012) Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review. Expert Review of Clinical Pharmacology 5:1, pages 31-42.
Read now
Alessandra Pugi, Loreta Longo, Alessandro Bartoloni, Gian Maria Rossolini, Alessandro Mugelli, Alfredo Vannacci & Francesco Lapi. (2012) Cardiovascular and metabolic safety profiles of the fluoroquinolones. Expert Opinion on Drug Safety 11:1, pages 53-69.
Read now
Richard W Grady. (2005) Systemic quinolone antibiotics in children: a review of the use and safety. Expert Opinion on Drug Safety 4:4, pages 623-630.
Read now

Articles from other publishers (26)

Prabhsimranjot Singh, Kristen L' Esperance, Amy Butler, Eric Yenulevich, Sonali Malhotra & Brett Glotzbecker. (2019) Ciprofloxacin-Associated Hypoglycemia. American Journal of Therapeutics 26:6, pages e717-e718.
Crossref
David R. P. Guay. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions 87 138 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 570 588 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 364 374 .
Nicole L. Varela, Federica Scavonetto, Toby N. Weingarten & Juraj Sprung. 2015. A Case Approach to Perioperative Drug-Drug Interactions. A Case Approach to Perioperative Drug-Drug Interactions 517 520 .
Yasuyoshi Ishiwata, Yutaka Takahashi, Masashi Nagata & Masato Yasuhara. (2013) Effects of Moxifloxacin on Serum Glucose Concentrations in Rats. Biological and Pharmaceutical Bulletin 36:4, pages 686-690.
Crossref
Mathieu S. Bolhuis, Prashant N. Panday, Arianna D. Pranger, Jos G. W. Kosterink & Jan-Willem C. Alffenaar. (2011) Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams. Pharmaceutics 3:4, pages 865-913.
Crossref
Chaker Ben Salem, Neila Fathallah, Houssem Hmouda & Kamel Bouraoui. (2011) Drug-Induced Hypoglycaemia. Drug Safety 34:1, pages 21-45.
Crossref
David R. P. Guay. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases 277 332 .
Jordan R. CovveyDaniel A. Lewis. (2010) Glimepiride-Induced Hypoglycemia with Ciprofloxacin, Metronidazole, and Acute Kidney Injury. Hospital Pharmacy 45:12, pages 934-938.
Crossref
Amy Arnold, Sara D. Brouse, William D. Pitcher & Ronald G. HallIIII. (2010) Empiric Therapy for Gram-Negative Pathogens in Nosocomial and Health Care-Associated Pneumonia: Starting With the End in Mind. Journal of Intensive Care Medicine 25:5, pages 259-270.
Crossref
Zachariah Thomas, Farooq Bandali, Karen McCowen & Atul Malhotra. (2010) Drug-induced endocrine disorders in the intensive care unit. Critical Care Medicine 38, pages S219-S230.
Crossref
Seth M. Garber, Melanie W. Pound & Susan M. Miller. (2009) Hypoglycemia associated with the use of levofloxacin. American Journal of Health-System Pharmacy 66:11, pages 1014-1019.
Crossref
HX Zheng, Y Huang, LA Frassetto & LZ Benet. (2008) Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite. Clinical Pharmacology & Therapeutics 85:1, pages 78-85.
Crossref
Daniel Tianfang Ge, Pui Ying Peggy Law, Siu-Kai Kong & Yuan-Yuan Ho. (2009) Disturbance of cellular glucose transport by two prevalently used fluoroquinolone antibiotics ciprofloxacin and levofloxacin involves glucose transporter type 1. Toxicology Letters 184:2, pages 81-84.
Crossref
Roshan J Lewis & John F MohrIIIIII. (2008) Dysglycaemias and Fluoroquinolones. Drug Safety 31:4, pages 283-292.
Crossref
Kerry L. LaPlante, Tracey L. Mersfelder, Kristina E. Ward & Brian J. Quilliam. (2012) Prevalence of and Risk Factors for Dysglycemia in Patients Receiving Gatifloxacin and Levofloxacin in an Outpatient Setting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:1, pages 82-89.
Crossref
Yoshitaka TAYAMA, Katsushi MIYAKE, Takami NAGAFUJI, Takako GOUHARA, Shushi MORITA, Shigeaki ARAI, Eiji SATO, Teruaki KITAURA & Kenji KIHIRA. (2007) Influence of Tacrolimus and Ciprofloxacin on Glucose Metabolismラット及びHIT-T15細胞の糖代謝に及ぼすTacrolimusとCiprofloxacinの影響. YAKUGAKU ZASSHI 127:11, pages 1883-1889.
Crossref
R.C.L. Page. 2007. 523 538 .
Alexander Imhof & Reto Laffer. 2007. 253 279 .
Edoardo Mannucci, Matteo Monami, Marco Mannucci, Veronica Chiasserini, Paola Nicoletti, Luciano Gabbani, Leonetto Giglioli, Giulio Masotti & Niccolò Marchionni. (2013) Incidence and prognostic significance of hypoglycemia in hospitalized non-diabetic elderly patients. Aging Clinical and Experimental Research 18:5, pages 446-451.
Crossref
Reamer L. Bushardt. (2006) Fluctuating Blood Glucose Levels in an Elderly Diabetic Patient. Southern Medical Journal 99:1, pages 10.
Crossref
R. Frothingham. (2005) Glucose Homeostasis Abnormalities Associated with Use of Gatifloxacin. Clinical Infectious Diseases 41:9, pages 1269-1276.
Crossref
John F. Mohr, Peggy S. McKinnon, Patti J. Peymann, Irene Kenton, Edward Septimus & Pablo C. Okhuysen. (2005) A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone. Pharmacotherapy 25:10, pages 1303-1309.
Crossref
James F. Graumlich, Saba Habis, Rosario R. Avelino, Sandra M. Salverson, Madhavi Gaddamanugu, Kiranmai Jamma & Jean C. Aldag. (2005) Hypoglycemia in Inpatients After Gatifloxacin or Levofloxacin Therapy: Nested Case-Control Study. Pharmacotherapy 25:10, pages 1296-1302.
Crossref
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:2, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.